Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 82

The DOI matches its Crossref record.

Hormone-related risk factors for breast cancer in women under age 50 years by estrogen and progesterone receptor status: results from a case-control and a case-case comparison

Ma, Huiyan, Bernstein, Leslie, Ross, Ronald K, Ursin, Giske · 2006 · Breast Cancer Research

Abstract

Introduction: It has been suggested that hormonal risk factors act predominantly on estrogen receptor and progesterone receptor (ER/PR)-positive breast cancers. However, the data have been inconsistent, especially in younger women. Methods: We evaluated the impact of age at menarche, pregnancy history, duration of breastfeeding, body mass index, combined oral contraceptive use, and alcohol consumption on breast cancer risk by ER/PR status in 1,725 population-based case patients and 440 control subjects aged 20 to 49 years identified within neighborhoods of case patients. We used multivariable unconditional logistic regression methods to conduct case–control comparisons overall as well as by ER/PR status of the cases, and to compare ER+PR+ with ER-PR- case patients. Results: The number of full-term pregnancies was inversely associated with the risk of ER+PR+ breast cancer (ptrend = 0.005), whereas recent average alcohol consumption was associated with an increased risk of ER+PR+ breast cancer (ptrend = 0.03). Neither of these two factors was associated with the risk of ER- PR- breast cancer. Late age at menarche and a longer duration of breastfeeding were both associated with decreased breast cancer risk, irrespective of receptor status (all ptrend≤ 0.03). Conclusion: Our results suggest that the number of full-term pregnancies and recent alcohol consumption affect breast cancer risk in younger women predominantly through estrogen and progesterone mediated by their respective receptors. Late age at menarche and breastfeeding may act through different hormonal mechanisms.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/bcr1514

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 40

  1. Henderson BE, Ross RK, Pike MC, Casagrande JT: Endogenous hormones as a major factor in human cancer. Cancer Res. 1982, 42: 3232-3239.
  2. Key TJ, Pike MC: The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol. 1988, 24: 29-43. 10.1016/0277-5379(88)90173-3. · DOI · Paper page
  3. Bernstein L, Ross RK: Endogenous hormones and breast cancer risk. Epidemiol Rev. 1993, 15: 48-65. · DOI · Paper page
  4. Gorski J, Gannon F: Current models of steroid hormone action: a critique. Annu Rev Physiol. 1976, 38: 425-450. 10.1146/annurev.ph.38.030176.002233. · DOI · Paper page
  5. Evans RM: The steroid and thyroid hormone receptor superfamily. Science. 1988, 240: 889-895. · DOI · Paper page
  6. Dickson RB, Stancel GM: Estrogen receptor-mediated processes in normal and cancer cells. J Natl Cancer Inst Monogr. 2000, 27: 135-145. · DOI · Paper page
  7. Anderson E: The role of oestrogen and progesterone receptors in human mammary development and tumorigenesis. Breast Cancer Res. 2002, 4: 197-201. 10.1186/bcr452. · DOI · Paper page
  8. Elwood JM, Godolphin W: Oestrogen receptors in breast tumours: associations with age, menopausal status and epidemiological and clinical features in 735 patients. Br J Cancer. 1980, 42: 635-644. · doi:10.1038/bjc.1980.296
  9. Hildreth NG, Kelsey JL, Eisenfeld AJ, LiVolsi VA, Holford TR, Fischer DB: Differences in breast cancer risk factors according to the estrogen receptor level of the tumor. J Natl Cancer Inst. 1983, 70: 1027-1031.
  10. Potter JD, Cerhan JR, Sellers TA, McGovern PG, Drinkard C, Kushi LR, Folsom AR: Progesterone and estrogen receptors and mammary neoplasia in the Iowa Women's Health Study: how many kinds of breast cancer are there?. Cancer Epidemiol Biomarkers Prev. 1995, 4: 319-326.
  11. Yasui Y, Potter JD: The shape of age-incidence curves of female breast cancer by hormone-receptor status. Cancer Causes Control. 1999, 10: 431-437. 10.1023/A:1008970121595. · DOI
  12. Huang WY, Newman B, Millikan RC, Schell MJ, Hulka BS, Moorman PG: Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status. Am J Epidemiol. 2000, 151: 703-714. · DOI · Paper page
  13. Zhu K, Beiler J, Hunter S, Payne-Wilks K, Roland CL, Forbes DS, Chinchilli VM, Bernard LJ, Jacobsen KH, Levine RS: The relationship between menstrual factors and breast cancer according to estrogen receptor status of tumor: a case-control study in African-American women. Ethn Dis. 2002, 12: S3-S23-9.
  14. Li CI, Daling JR, Malone KE: Incidence of invasive breast cancer by hormone receptor status from 1992 to 1998. J Clin Oncol. 2003, 21: 28-34. 10.1200/JCO.2003.03.088. · DOI · Paper page
  15. Stanford JL, Greenberg RS: Breast cancer incidence in young women by estrogen receptor status and race. Am J Public Health. 1989, 79: 71-73. · DOI
  16. Habel LA, Stanford JL: Hormone receptors and breast cancer. Epidemiol Rev. 1993, 15: 209-219. · DOI
  17. Althuis MD, Fergenbaum JH, Garcia-Closas M, Brinton LA, Madigan MP, Sherman ME: Etiology of hormone receptor-defined breast cancer: a systematic review of the literature. Cancer Epidemiol Biomarkers Prev. 2004, 13: 1558-1568. · DOI · Paper page
  18. Colditz GA, Rosner BA, Chen WY, Holmes MD, Hankinson SE: Risk factors for breast cancer according to estrogen and progesterone receptor status. J Natl Cancer Inst. 2004, 96: 218-228. · DOI · Paper page
  19. Britton JA, Gammon MD, Schoenberg JB, Stanford JL, Coates RJ, Swanson CA, Potischman N, Malone KE, Brogan DJ, Daling JR, et al: Risk of breast cancer classified by joint estrogen receptor and progesterone receptor status among women 20–44 years of age. Am J Epidemiol. 2002, 156: 507-516. 10.1093/aje/kwf065. · DOI
  20. McCredie MR, Dite GS, Southey MC, Venter DJ, Giles GG, Hopper JL: Risk factors for breast cancer in young women by oestrogen receptor and progesterone receptor status. Br J Cancer. 2003, 89: 1661-1663. 10.1038/sj.bjc.6601293. · doi:10.1038/sj.bjc.6601293
  21. Ursin G, Bernstein L, Lord S, Karim JR, Deapen D, Press MF, Daling JR, Norman SA, Liff JM, Marchbanks PA, et al: Reproductive factors and subtypes of breast cancer defined by hormone receptor and histology. Br J Cancer. 2005, 93: 364-371. 10.1038/sj.bjc.6602712. · DOI
  22. Cotterchio M, Kreiger N, Theis B, Sloan M, Bahl S: Hormonal factors and the risk of breast cancer according to estrogen- and progesterone-receptor subgroup. Cancer Epidemiol Biomarkers Prev. 2003, 12: 1053-1060.
  23. Bernstein L, Henderson BE, Hanisch R, Sullivan-Halley J, Ross RK: Physical exercise and reduced risk of breast cancer in young women. J Natl Cancer Inst. 1994, 86: 1403-1408. · DOI · Paper page
  24. Ursin G, Peters RK, Henderson BE, d'Ablaing G, Monroe KR, Pike MC: Oral contraceptive use and adenocarcinoma of cervix. Lancet. 1994, 344: 1390-1394. 10.1016/S0140-6736(94)90567-3. · DOI
  25. Marchbanks PA, McDonald JA, Wilson HG, Burnett NM, Daling JR, Bernstein L, Malone KE, Strom BL, Norman SA, Weiss LK, et al: The NICHD Women's Contraceptive and Reproductive Experiences Study: methods and operational results. Ann Epidemiol. 2002, 12: 213-221. 10.1016/S1047-2797(01)00274-5. · DOI
  26. Pagano M, Gauvreau K: Principles of Biostatistics. 2000, Pacific Grove, CA: Duxbury Press, 2
  27. Hosmer DW, Lemeshow S: Applied Logistic Regression. 2000, New York, NY: Wiley-Interscience · DOI · Paper page
  28. Chu KC, Anderson WF: Rates for breast cancer characteristics by estrogen and progesterone receptor status in the major racial/ethnic groups. Breast Cancer Res Treat. 2002, 74: 199-211. 10.1023/A:1016361932220. · DOI
  29. Rothman KJ, Greenland S: Modern Epidemiology. 1998, Philadelphia: Lippincott-Raven
  30. Russo J, Rivera R, Russo IH: Influence of age and parity on the development of the human breast. Breast Cancer Res Treat. 1992, 23: 211-218. 10.1007/BF01833517. · DOI · Paper page
  31. Russo J, Hu YF, Yang X, Russo IH: Developmental, cellular, and molecular basis of human breast cancer. J Natl Cancer Inst Monogr. 2000, 27: 17-37. · DOI · Paper page
  32. Liu Q, Wuu J, Lambe M, Hsieh S-F, Ekbom A, Hsieh C-C: Transient increase in breast cancer risk after giving birth: postpartum period with the highest risk (Sweden). Cancer Causes Control. 2002, 13: 299-305. 10.1023/A:1015287208222. · DOI
  33. Enger SM, Ross RK, Paganini-Hill A, Carpenter CL, Bernstein L: Body size, physical activity, and breast cancer hormone receptor status: results from two case-control studies. Cancer Epidemiol Biomarkers Prev. 2000, 9: 681-687.
  34. Pike MC: Reducing cancer risk in women through lifestyle-mediated changes in hormone levels. Cancer Detect Prev. 1990, 14: 595-607.
  35. Westhoff C, Gentile G, Lee J, Zacur H, Helbig D: Predictors of ovarian steroid secretion in reproductive-age women. Am J Epidemiol. 1996, 144: 381-388. · DOI
  36. McDonald JA, Mandel MG, Marchbanks PA, Folger SG, Daling JR, Ursin G, Simon MS, Bernstein L, Strom BL, Norman SA, et al: Alcohol exposure and breast cancer: results of the women's contraceptive and reproductive experiences study. Cancer Epidemiol Biomarkers Prev. 2004, 13: 2106-2116. · DOI
  37. Enger SM, Ross RK, Paganini-Hill A, Longnecker MP, Bernstein L: Alcohol consumption and breast cancer oestrogen and progesterone receptor status. Br J Cancer. 1999, 79: 1308-1314. 10.1038/sj.bjc.6690210. · DOI
  38. Mendelson JH, Lukas SE, Mello NK, Amass L, Ellingboe J, Skupny A: Acute alcohol effects on plasma estradiol levels in women. Psychopharmacology. 1988, 94: 464-467. 10.1007/BF00212838. · DOI
  39. Reichman ME, Judd JT, Longcope C, Schatzkin A, Clevidence BA, Nair PP, Campbell WS, Taylor PR: Effects of alcohol consumption on plasma and urinary hormone concentrations in premenopausal women. J Natl Cancer Inst. 1993, 85: 722-727. · DOI · Paper page
  40. Dontu G, El-Ashry D, Wicha MS: Breast cancer, stem/progenitor cells and the estrogen receptor. Trends Endocrinol Metab. 2004, 15: 193-197. 10.1016/j.tem.2004.05.011. · DOI · Paper page

Cited by

Metadata

Authors
Ma, H., Bernstein, L., Ross, R. K., & Ursin, G.
Venue
Breast Cancer Research
Published
2006-07-17
Volume
8
Issue
4
ISSN
1465-542X
Cited by
82
References
0
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.